Author

Neetigyata Singh

University of Colorado Anschutz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

M. FrancisiD· 1 shared Maki NakayamaiD· 1 shared Matthew A. BurchilliD· 1 shared Michael C. YarnelliD· 1 shared Ross M. KedliD· 1 shared Terry J. FryiD· 1 shared Winston HibleriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

M. FrancisORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

High Precision Peptide-MHC Class I CARs Enhance In Vivo Killing ofTargeted CD8 T Cells to Prevent Type 1 Diabetes in Novel RIP-mOVA Model

M. Francis, Winston Hibler, Michael C. Yarnell, Neetigyata Singh, Ross M. Kedl, Matthew A. Burchill, Terry J. Fry, Maki Nakayama

This paper develops a peptide-MHC Class I CAR platform that enhances in vivo killing of antigen-specific CD8 T cells and prevents type 1 diabetes in a novel RIP-mOVA model.

bioRxiv · Nov 10, 2025 · PreprintImmunology